• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to: "NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues".

作者信息

Ji Dong, Cheng Gregory, Lau George

机构信息

The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.

Faculty of Health Science, University of Macau; Humanity and Health Clinical Trial Center, Humanity & Health Medical Group, Hong Kong SAR, China.

出版信息

J Hepatol. 2021 Feb;74(2):484-485. doi: 10.1016/j.jhep.2020.10.020. Epub 2020 Oct 29.

DOI:10.1016/j.jhep.2020.10.020
PMID:33130185
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7598754/
Abstract
摘要

相似文献

1
Reply to: "NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues".回复：“非酒精性脂肪性肝病是新冠住院患者肝损伤的预测指标，但不是死亡率、就诊时疾病严重程度或疾病进展的预测指标——争论仍在继续”
J Hepatol. 2021 Feb;74(2):484-485. doi: 10.1016/j.jhep.2020.10.020. Epub 2020 Oct 29.
2
NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues.非酒精性脂肪性肝病是新冠病毒肺炎住院患者肝损伤的一个预测指标，但不是死亡率、就诊时疾病严重程度或病情进展的预测指标——争论仍在继续。
J Hepatol. 2021 Feb;74(2):482-484. doi: 10.1016/j.jhep.2020.09.006. Epub 2020 Nov 19.
3
Reply to: 'NAFLD or comorbidities, that is the question'.
J Hepatol. 2020 Sep;73(3):724-725. doi: 10.1016/j.jhep.2020.05.006. Epub 2020 May 12.
4
Non-Alcoholic Fatty Liver Disease and COVID-19-Two Pandemics Hitting at the Same Time.非酒精性脂肪性肝病与 COVID-19：双重疫情夹击
Medicina (Kaunas). 2021 Oct 3;57(10):1057. doi: 10.3390/medicina57101057.
5
NAFLD or comorbidities, that is the question.非酒精性脂肪性肝病还是合并症，这才是问题所在。
J Hepatol. 2020 Sep;73(3):723. doi: 10.1016/j.jhep.2020.04.026. Epub 2020 Apr 22.
6
Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.代谢功能障碍相关脂肪性肝病且纤维化评分升高的患者感染新型冠状病毒肺炎后出现重症的风险。
Gut. 2020 Aug;69(8):1545-1547. doi: 10.1136/gutjnl-2020-321611. Epub 2020 May 15.
7
No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease.在代谢相关脂肪性肝病中，没有证据表明严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的肝脏摄取增加。
J Hepatol. 2020 Sep;73(3):717-718. doi: 10.1016/j.jhep.2020.04.035. Epub 2020 Apr 30.
8
Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.致编辑的信：肥胖作为代谢相关脂肪性肝病患者中COVID-19病情更严重的危险因素
Metabolism. 2020 Jul;108:154256. doi: 10.1016/j.metabol.2020.154256. Epub 2020 Apr 29.
9
Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.新型冠状病毒肺炎患者肝损伤的发生率及其与临床结局的相关性：系统评价与荟萃分析。
Eur Rev Med Pharmacol Sci. 2020 Dec;24(24):13072-13088. doi: 10.26355/eurrev_202012_24215.
10
Comparison of patients hospitalized with COVID-19, H7N9 and H1N1.比较因 COVID-19、H7N9 和 H1N1 住院的患者。
Infect Dis Poverty. 2020 Dec 2;9(1):163. doi: 10.1186/s40249-020-00781-5.

引用本文的文献

1
Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease.COVID-19 对代谢相关脂肪性肝病患者的临床影响。
World J Gastroenterol. 2023 Jan 21;29(3):487-502. doi: 10.3748/wjg.v29.i3.487.
2
COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2 Infection and MAFLD.COVID-19 大流行：对 SARS-CoV-2 感染与 MAFLD 之间相互作用的深入了解。
Int J Biol Sci. 2022 Jul 11;18(12):4756-4767. doi: 10.7150/ijbs.72461. eCollection 2022.
3
Liver Injury and Elevated FIB-4 Define a High-Risk Group in Patients with COVID-19.肝损伤和FIB-4升高界定了COVID-19患者中的高危群体。
J Clin Med. 2021 Dec 28;11(1):153. doi: 10.3390/jcm11010153.
4
Coronavirus disease 2019 and non-alcoholic fatty liver disease.2019冠状病毒病与非酒精性脂肪性肝病
World J Hepatol. 2021 Sep 27;13(9):969-978. doi: 10.4254/wjh.v13.i9.969.
5
Coronavirus Disease-2019 (COVID-19) and the Liver.2019冠状病毒病（COVID-19）与肝脏
J Clin Transl Hepatol. 2021 Apr 28;9(2):247-255. doi: 10.14218/JCTH.2021.00006. Epub 2021 Mar 22.
6
Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Children With Liver Transplant and Native Liver Disease: An International Observational Registry Study.儿童肝移植和原发性肝病中严重急性呼吸综合征冠状病毒 2 感染：一项国际观察性登记研究。
J Pediatr Gastroenterol Nutr. 2021 Jun 1;72(6):807-814. doi: 10.1097/MPG.0000000000003077.
7
APASL practical recommendations for the management of hepatocellular carcinoma in the era of COVID-19.亚太肝脏研究学会（APASL）在 COVID-19 时代管理肝细胞癌的实用建议。
Hepatol Int. 2020 Dec;14(6):920-929. doi: 10.1007/s12072-020-10103-4. Epub 2020 Nov 11.